The aim of the present study was to use this highly sensitive methodology to directly compare the mutational status of PIK3CA (E545K, H1047R) in CTC‐DNAs isolated from CellSearch® cartridges and paired plasma‐ctDNA from the same blood draws in patients with early and metastatic BrCa. This evidence concerns the gene PIK3CA and invasive breast carcinoma.